Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al

Acta Diabetol. 2023 Jan;60(1):141-142. doi: 10.1007/s00592-022-01996-8. Epub 2022 Oct 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus, Type 1* / drug therapy
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin Glargine
  • Insulin, Long-Acting / therapeutic use
  • Pregnancy
  • Pregnancy Outcome

Substances

  • insulin degludec
  • Insulin, Long-Acting
  • Hypoglycemic Agents
  • Insulin Glargine
  • Blood Glucose